While targeted cancer drugs are often compared to tranquilizer darts for their ability to target a specific gene causing rapid cell growth, not all tumors share this characteristic. In fact, many tumors grow because of broken or missing genes that regulate cell growth and self-destruct when necessary. This has presented a significant challenge for researchers in the fight against cancer.
Unlike hyperactive genes, repairing or replacing broken or missing proteins in these tumors is a complex and challenging task. Tumors that lack proper regulation from “tumor-suppressor” genes are more common than those caused by a single gene mutation. This poses a significant hurdle in the fight against cancer, as restoring these genes is a complex and challenging task.
For many years, researchers have been working to develop new treatments that can effectively target and destroy these types of tumors. While progress has been made, there is still much work to be done. The fight against cancer is ongoing, but with continued research and innovation, hope remains for those affected by this debilitating disease.
